An Approval & a Rejection. Both Considered Good News. A Small Firm is Added to the Prohost Portfolio
May 7, 2018 0
The Week in Review #22 What Went Right or Wrong in the Biotech Sector During the Departing Week? - A lot happened in the biotech sector during the week, which departed at midnight. Topping the list of the week’s events was the approval of Portola’s (PTLA) product Andexxa . . . This content is for paid subscribers. Please click here to subscribe or here to log in.